Radiopharmaceuticals
Page 1 • 3 itemsUnlock global radiopharmaceutical market insights. NovaPharmaNews delivers critical intelligence for investors, BD, and analysts on nuclear medicine innovation.
PeptiDream Partner Asahi Kasei Therapeutics Initiates Phase 1 Clinical Trial for AK1940
Asahi Kasei Therapeutics begins Phase 1 clinical trial for AK1940, developed through collaboration with PeptiDream Inc., marking key milestone in drug development.
Methylphenidate Shortage Update: Concerta and Ritalin LA Supply Restored, Rubifen LA Expected by June 2026
Australia's methylphenidate shortage shows improvement as Concerta and Ritalin LA supplies normalize, while Rubifen LA shortages persist until mid-2026.
Perceptive Discovery Partners with MH3D to Launch α-Sight™ Alpha Radiopharmaceutical Imaging Platform
Perceptive Discovery announces strategic partnership with MH3D and launches α-Sight™ preclinical imaging platform for alpha-emitting radiopharmaceuticals in oncology.